F. Djouad, C. Bouffi, S. Ghannam, D. Noel, and C. Jorgensen, Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases, Nat Rev Rheumatol, vol.5, issue.7, pp.392-401, 2009.

L. Yan, D. Zheng, and R. H. Xu, Critical role of tumor necrosis factor signaling in mesenchymal stem cell-based therapy for autoimmune and inflammatory diseases, Front Immunol, vol.9, p.1658, 2018.

L. Jorgensen, C. Djouad, and F. , Mesenchymal stem cells direct the immunological fate of macrophages, Results Probl Cell Differ, vol.62, pp.61-72, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01520064

J. Su, X. Chen, Y. Huang, W. Li, J. Li et al., Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species, Cell Death Differ, vol.21, issue.3, pp.388-96, 2014.

A. Augello, R. Tasso, S. M. Negrini, A. Amateis, F. Indiveri et al., Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway, Eur J Immunol, vol.35, issue.5, pp.1482-90, 2005.

C. Bouffi, C. Bony, G. Courties, C. Jorgensen, and D. Noel, IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis, PLoS One, vol.5, issue.12, p.14247, 2010.

K. English, J. M. Ryan, L. Tobin, M. J. Murphy, F. P. Barry et al., Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(high) forkhead box P3+ regulatory T cells, Clin Exp Immunol, vol.156, issue.1, pp.149-60, 2009.

Z. Selmani, A. Naji, I. Zidi, B. Favier, E. Gaiffe et al., Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells, Stem Cells, vol.26, issue.1, pp.212-234, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00483522

S. Ghannam, J. Pene, G. Torcy-moquet, C. Jorgensen, and H. Yssel, Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype, J Immunol, vol.185, issue.1, pp.302-314, 2010.
URL : https://hal.archives-ouvertes.fr/hal-02193434

A. Rozenberg, A. Rezk, M. N. Boivin, P. J. Darlington, M. Nyirenda et al., Human mesenchymal stem cells impact Th17 and Th1 responses through a prostaglandin E2 and myeloiddependent mechanism, Stem Cells Transl Med, vol.5, issue.11, pp.1506-1520, 2016.

P. Luz-crawford, D. Noel, X. Fernandez, M. Khoury, F. Figueroa et al., Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway, PLoS One, vol.7, issue.9, p.45272, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00758222

F. Djouad, P. Plence, C. Bony, P. Tropel, F. Apparailly et al., Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals, Blood, vol.102, issue.10, pp.3837-3881, 2003.

G. Ren, X. Zhao, L. Zhang, J. Zhang, L. Huillier et al., Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression, J Immunol, vol.184, issue.5, pp.2321-2329, 2010.

K. English, F. P. Barry, C. P. Field-corbett, and B. P. Mahon, IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells, Immunol Lett, vol.110, issue.2, pp.91-100, 2007.

N. Mombo, B. Gerbal-chaloin, S. Bokus, A. Daujat-chavanieu, M. Jorgensen et al., MitoCeption: transferring isolated human MSC mitochondria to glioblastoma stem cells, J vis Exp, vol.120, p.55245, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01777706

T. Ahmad, S. Mukherjee, B. Pattnaik, M. Kumar, S. Singh et al., Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy, EMBO J, vol.33, issue.9, pp.994-1010, 2014.

A. Caicedo, V. Fritz, J. M. Brondello, M. Ayala, I. Dennemont et al., MitoCeption as a new tool to assess the effects of mesenchymal stem/stromal cell mitochondria on cancer cell metabolism and function, Sci Rep, vol.5, p.9073, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01834600

V. A. Babenko, D. N. Silachev, V. A. Popkov, L. D. Zorova, I. B. Pevzner et al., Miro1 enhances mitochondria transfer from multipotent mesenchymal stem cells (MMSC) to neural cells and improves the efficacy of cell recovery, Molecules, vol.23, issue.3, 2018.

S. Paliwal, R. Chaudhuri, A. Agrawal, and S. Mohanty, Regenerative abilities of mesenchymal stem cells through mitochondrial transfer, J Biomed Sci, vol.25, issue.1, p.31, 2018.

S. Paliwal, R. Chaudhuri, A. Agrawal, and S. Mohanty, Human tissue-specific MSCs demonstrate differential mitochondria transfer abilities that may determine their regenerative abilities, Stem Cell Res Ther, vol.9, issue.1, p.298, 2018.

F. Djouad, C. Bony, T. Haupl, G. Uze, N. Lahlou et al., Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells, Arthritis Res Ther, vol.7, issue.6, pp.1304-1319, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-00089978

E. A. Lyons, M. K. Scheible, K. Sturk-andreaggi, J. A. Irwin, and R. S. Just, A highthroughput Sanger strategy for human mitochondrial genome sequencing, BMC Genomics, vol.14, p.881, 2013.

J. Wang, X. Liu, Y. Qiu, Y. Shi, J. Cai et al., Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells, J Hematol Oncol, vol.11, issue.1, p.11, 2018.

K. A. Frauwirth, J. L. Riley, M. H. Harris, R. V. Parry, J. C. Rathmell et al., The CD28 signaling pathway regulates glucose metabolism, Immunity, vol.16, issue.6, pp.769-77, 2002.

R. G. Jones and E. J. Pearce, MenTORing immunity: mTOR signaling in the development and function of tissue-resident immune cells, Immunity, vol.46, issue.5, pp.730-772, 2017.

V. A. Gerriets, R. J. Kishton, J. Mo, S. Cohen, P. J. Siska et al., Foxp3 and Tolllike receptor signaling balance Treg cell anabolic metabolism for suppression, Nat Immunol, vol.17, issue.12, pp.1459-66, 2016.

G. J. Van-der-windt and P. El, Metabolic switching and fuel choice during T-cell differentiation and memory development, Immunol Rev, vol.249, issue.1, pp.27-42, 2012.

E. L. Mills, B. Kelly, A. Logan, A. Costa, M. Varma et al., Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages, Cell, vol.167, issue.2, pp.457-70, 2016.

R. Wang and D. R. Green, Metabolic checkpoints in activated T cells, Nat Immunol, vol.13, issue.10, pp.907-922, 2012.

M. J. Park, S. H. Lee, S. H. Lee, E. J. Lee, E. K. Kim et al., IL-1 receptor blockade alleviates graft-versus-host disease through downregulation of an interleukin-1beta-dependent glycolytic pathway in Th17 cells, Mediat Inflamm, p.631384, 2015.

L. Z. Shi, R. Wang, G. Huang, P. Vogel, N. G. Green et al., HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells, J Exp Med, vol.208, issue.7, pp.1367-76, 2011.

M. Biniecka, M. Canavan, T. Mcgarry, W. Gao, J. Mccormick et al., Dysregulated bioenergetics: a key regulator of joint inflammation, Ann Rheum Dis, vol.75, issue.12, pp.2192-200, 2016.

B. Cillero-pastor, M. A. Martin, J. Arenas, M. J. Lopez-armada, and F. J. Blanco, Effect of nitric oxide on mitochondrial activity of human synovial cells, BMC Musculoskelet Disord, vol.12, p.42, 2011.

J. Chen, Q. Wang, X. Feng, Z. Zhang, L. Geng et al., Umbilical cord-derived mesenchymal stem cells suppress autophagy of T cells in patients with systemic lupus erythematosus via transfer of mitochondria, Stem Cells Int, p.4062789, 2016.